Malaria News and Research

Latest Malaria News and Research

Ten health care innovations could save lives of mothers and children

Ten health care innovations, if brought to scale immediately in low-resource countries, could have the potential to save the lives of some 1.2 million mothers and children in 2015.

26 Sep 2013

UK contributes £1billion to Global Fund to Fight AIDS, Tubercolosis and Malaria

IVCC today commended the United Kingdom following the announcement that the UK will contribute £1billion (US $1.6 billion) over the next three years to The Global Fund to Fight AIDS, Tubercolosis and Malaria.

25 Sep 2013

JPM, Bill & Melinda Gates Foundation announces capital raise for first-of-its-kind investment product

A new investment fund structured by JPMorgan Chase & Co. (NYSE: JPM) and the Bill & Melinda Gates Foundation will, for the first time, allow individual and institutional investors the opportunity to finance late-stage global health technologies that have the potential to save millions of lives in low-income countries.

24 Sep 2013

Pretravel consultations, malaria preventive medications save money for travelers to West Africa

Not only do U.S. travelers to West Africa who consult health providers before they leave and take prescribed preventive medications substantially reduce their risk of contracting malaria, they also reduce costs to their health insurance providers and, in most cases, to themselves.

24 Sep 2013

The quest to end extreme poverty

World leaders will join a chorus of music legends, celebrities such as Katie Holmes and Gerard Butler, and 60,000 Global Citizens on September 28, 2013 on the Great Lawn of New York's iconic Central Park.

21 Sep 2013

Equatorial Guinea presents design for malaria vaccine trial

Equatorial Guinea's Ministry of Health and Social Security recently presented a design for a malaria vaccine trial as part of the government's efforts to improve the country's public health.

21 Sep 2013

Study explains indirect burden of malaria on childhood deaths

Recurrent episodes of malaria cause chronic inflammation in blood vessels that might predispose to future infections and may increase susceptibility to cardiovascular disease, a Wellcome Trust study in Malawian children finds.

20 Sep 2013

ChipCare’s handheld analyzer secures largest investments in Canada's healthcare sector

An innovative, handheld point-of-care analyzer, developed by ChipCare Corporation, has secured one of the largest ever angel investments in Canada's healthcare sector. Phase II financing has closed, with an investment of $2.05M to support ChipCare's continuing development and commercialization over the next three years.

16 Sep 2013

Combination therapies: Cost-effective alternative to treat visceral leishmaniasis

Visceral leishmaniasis is the second-deadliest parasitic disease after malaria. Each year, thousands fall victim among poor and marginalised populations in low-income countries.

16 Sep 2013

Climate change not likely to make malaria situation worse in West Africa, say researchers

As public-health officials continue to fight malaria in sub-Saharan Africa, researchers are trying to predict how climate change will impact the disease, which infected an estimated 219 million people in 2010 and is the fifth leading cause of death worldwide among children under age 5.

16 Sep 2013

New report shows 6.6 million children under 5 died in 2012

In 2012, approximately 6.6 million children worldwide - 18 000 children per day - died before reaching their fifth birthday, according to a new report released today by UNICEF, WHO, the World Bank Group and the United Nations Department of Economic and Social Affairs/Population Division. This is roughly half the number of under-fives who died in 1990, when more than 12 million children died.

13 Sep 2013

UK DfID awards IVCC £12 million to develop new insecticides to fight malaria

IVCC has been awarded £12 million over the next five years by the UK Department for International Development (DfID) to support the development of new insecticides to combat malaria.

12 Sep 2013

Scientists develop novel, rapid way to test artemisinin-resistant malaria

For the first time, scientists have developed a novel and rapid way to test whether the most common and lethal form of malaria is resistant to potent artemisinin drugs.

12 Sep 2013

Study suggests new path to make protective malaria vaccine

This study suggests that genetically engineered malaria parasites that are stunted through precise gene deletions (genetically attenuated parasites, or "GAP") could be used as a vaccine that protects against malaria infection. This means that the harmless (attenuated) version of the parasite would interact with the body in the same way as the infective version, but without possibility of causing disease.

11 Sep 2013

Better ways to combat mosquitoes

In an advance toward providing mosquito-plagued people, pets and livestock with an invisibility cloak against these blood-sucking insects, scientists today described discovery of substances that occur naturally on human skin and block mosquitoes’ ability to smell and target their victims.

11 Sep 2013

Roche, Inovio Pharmaceuticals to develop DNA-based vaccines for prostate cancer and hepatitis B

Roche and Inovio Pharmaceuticals, Inc. announced today that they have entered into an exclusive worldwide license agreement to research, develop and commercialize Inovio's highly-optimized, multi-antigen DNA immunotherapies targeting prostate cancer and hepatitis B.

10 Sep 2013

Iron deficiency anemia may offer protection against malaria infection

Children in a malaria-endemic community in Ghana who received a micronutrient powder with iron did not have an increased incidence of malaria, according to a study in the September 4 issue of JAMA. Previous research has suggested that iron supplementation for children with iron deficiency in malaria-endemic areas may increase the risk of malaria.

4 Sep 2013

Imaxio's pro-immunogenic technology used in tuberculosis vaccine phase I clinical study

Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.

3 Sep 2013

Study: Mosquitoes able to smell major human host odorants better at night

In work published this week in Nature: Scientific Reports, a team of researchers from the University of Notre Dame's Eck Institute for Global Health, led by Associate Professor Giles Duffield and Assistant Professor Zain Syed of the Department of Biological Sciences, revealed that the major malaria vector in Africa, the Anopheles gambiae mosquito, is able to smell major human host odorants better at night.

31 Aug 2013

New method that targets mosquito larvae and pupae may help control malaria

A malaria control method that targets mosquito larvae and pupae as they mature in standing water could be an important supplementary measure in the fight against the disease, according to a new report.

29 Aug 2013

Malaria News and Research

Latest Malaria News and Research

Ten health care innovations could save lives of mothers and children

UK contributes £1billion to Global Fund to Fight AIDS, Tubercolosis and Malaria

JPM, Bill & Melinda Gates Foundation announces capital raise for first-of-its-kind investment product

Pretravel consultations, malaria preventive medications save money for travelers to West Africa

The quest to end extreme poverty

Equatorial Guinea presents design for malaria vaccine trial

Study explains indirect burden of malaria on childhood deaths

ChipCare’s handheld analyzer secures largest investments in Canada's healthcare sector

Combination therapies: Cost-effective alternative to treat visceral leishmaniasis

Climate change not likely to make malaria situation worse in West Africa, say researchers

New report shows 6.6 million children under 5 died in 2012

UK DfID awards IVCC £12 million to develop new insecticides to fight malaria

Scientists develop novel, rapid way to test artemisinin-resistant malaria

Study suggests new path to make protective malaria vaccine

Better ways to combat mosquitoes

Roche, Inovio Pharmaceuticals to develop DNA-based vaccines for prostate cancer and hepatitis B

Iron deficiency anemia may offer protection against malaria infection

Imaxio's pro-immunogenic technology used in tuberculosis vaccine phase I clinical study

Study: Mosquitoes able to smell major human host odorants better at night

New method that targets mosquito larvae and pupae may help control malaria

Industry Focus: Cell & Gene Therapy eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Malaria News and Research

Latest Malaria News and Research

Industry Focus: Cell & Gene Therapy eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in